Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24786352 | 0.90 | L3MBTL1 (0.49) | L3MBTL1NAAAGRIN1GRIN2ALMNA | |
| SCHEMBL14279162 | 0.82 | L3MBTL1 (0.53) | L3MBTL1NAAAGRIN1GRIN2ANPC1 | |
| SCHEMBL14279160 | 0.78 | NAAA (0.60) | L3MBTL1NAAAMEN1ALDH1A1KMT2A | |
| SCHEMBL2250363 | 0.77 | L3MBTL1 (0.62) | L3MBTL1LMNANPC1RAB9A | |
| SCHEMBL506059 | 0.76 | NAAA (0.65) | L3MBTL1NAAAMEN1ALDH1A1KMT2A | |
| SCHEMBL506060 | 0.76 | NAAA (0.65) | L3MBTL1NAAAMEN1ALDH1A1KMT2A | |
| SCHEMBL10543883 | 0.74 | GRIA1 (0.71) | L3MBTL1CTSLCTSSCTSK | |
| SCHEMBL10543878 | 0.74 | GRIA1 (0.71) | L3MBTL1CTSLCTSSCTSK | |
| SCHEMBL2244204 | 0.74 | L3MBTL1 (0.61) | L3MBTL1NPC1RAB9A | |
| SCHEMBL6184058 | 0.73 | CTSL (0.68) | CTSLCTSBCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401554-A1 | USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES | CORNELL UNIVERSITY | 2022-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401554-A1 | USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES | PIGS, VMA21, FURIN | L3MBTL1 4157/4885NAAA 428/4885MEN1 1126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.